ISOCAINE HYDROCHLORIDE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Isocaine Hydrochloride, and when can generic versions of Isocaine Hydrochloride launch?
Isocaine Hydrochloride is a drug marketed by Septodont and is included in two NDAs.
The generic ingredient in ISOCAINE HYDROCHLORIDE is levonordefrin; mepivacaine hydrochloride. There are two drug master file entries for this compound. Additional details are available on the levonordefrin; mepivacaine hydrochloride profile page.
Summary for ISOCAINE HYDROCHLORIDE
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 2 |
Raw Ingredient (Bulk) Api Vendors: | 113 |
Patent Applications: | 1,009 |
Formulation / Manufacturing: | see details |
DailyMed Link: | ISOCAINE HYDROCHLORIDE at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for ISOCAINE HYDROCHLORIDE
US Patents and Regulatory Information for ISOCAINE HYDROCHLORIDE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Septodont | ISOCAINE HYDROCHLORIDE | mepivacaine hydrochloride | INJECTABLE;INJECTION | 080925-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Septodont | ISOCAINE HYDROCHLORIDE W/ LEVONORDEFRIN | levonordefrin; mepivacaine hydrochloride | INJECTABLE;INJECTION | 084697-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |